Seminars in Cancer Biology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 1, 2024
Elevated
lipid
metabolism
is
one
of
hallmarks
malignant
tumors.
Lipids
not
only
serve
as
essential
structural
components
biological
membranes
but
also
provide
energy
and
substrates
for
the
proliferation
cancer
cells
tumor
growth.
Cancer
meet
their
needs
by
coordinating
processes
absorption,
synthesis,
transport,
storage,
catabolism.
As
research
in
this
area
continues
to
deepen,
numerous
new
discoveries
have
emerged,
making
it
crucial
scientists
stay
informed
about
developments
metabolism.
In
review,
we
first
discuss
relevant
concepts
theories
or
assumptions
that
help
us
understand
-based
therapies.
We
then
systematically
summarize
latest
advancements
including
mechanisms,
novel
targets,
up-to-date
pre-clinical
clinical
investigations
anti-cancer
treatment
with
targeted
drugs.
Finally,
emphasize
emerging
directions
therapeutic
strategies,
future
prospective
challenges.
This
review
aims
insights
guidance
field
Healthcare,
Journal Year:
2022,
Volume and Issue:
10(9), P. 1616 - 1616
Published: Aug. 25, 2022
Obesity
is
a
chronic
disease
characterized
by
the
abnormal
or
excessive
accumulation
of
body
fat,
affecting
more
than
1
billion
people
worldwide.
commonly
associated
with
other
metabolic
disorders,
such
as
type
2
diabetes,
non-alcoholic
fatty
liver
disease,
cardiovascular
diseases,
kidney
and
cancers.
Factors
sedentary
lifestyle,
overnutrition,
socioeconomic
status,
environmental
genetic
conditions
can
cause
obesity.
Many
molecules
signaling
pathways
are
involved
in
pathogenesis
obesity,
nuclear
factor
(NF)-κB,
Toll-like
receptors
(TLRs),
adhesion
molecules,
G
protein-coupled
(GPCRs),
programmed
cell
death
(PD-1)/programmed
death-ligand
(PD-L1),
sirtuin
(SIRT1).
Commonly
used
strategies
obesity
management
treatment
include
exercise
dietary
change
restriction
for
early
stage
bariatric
surgery
server
Food
Drug
Administration
(FDA)-approved
medicines
semaglutide
liraglutide
that
be
monotherapy
synergistic
treatment.
In
addition,
psychological
management,
especially
patients
distress,
good
option.
Gut
microbiota
plays
an
important
role
its
comorbidities,
gut
microbial
reprogramming
fecal
transplantation
(FMT),
probiotics,
prebiotics,
synbiotics
shows
promising
potential
syndrome.
clinical
trials
ongoing
to
evaluate
therapeutic
effects
different
treatments.
Currently,
prevention
best
options
prevent
progression
many
comorbidities.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Oct. 9, 2024
Metabolism,
including
glycolysis,
oxidative
phosphorylation,
fatty
acid
oxidation,
and
other
metabolic
pathways,
impacts
the
phenotypes
functions
of
immune
cells.
The
regulation
system
is
important
in
pathogenesis
progression
numerous
diseases,
such
as
cancers,
autoimmune
diseases
diseases.
concept
immunometabolism
was
introduced
over
a
decade
ago
to
elucidate
intricate
interplay
between
metabolism
immunity.
definition
has
expanded
from
chronic
low-grade
inflammation
reprogramming
cells
various
With
being
proposed
developed,
can
be
gradually
summarized
becomes
more
clearer.
In
context
many
cancer,
disease,
occurs
inducing
proinflammatory
or
anti-inflammatory
effects.
phenotypic
functional
changes
caused
by
further
affect
development
Based
on
experimental
results,
targeting
cellular
promising
therapy.
this
review,
we
focus
introduce
their
pathways
reprogramming,
summarize
how
these
effects
We
thoroughly
explore
targets
treatments
based
existing
studies.
challenges
translating
results
into
clinical
applications
field
are
also
summarized.
believe
that
better
understanding
health
will
improve
management
most
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 3, 2025
Targeting
cholesterol
metabolism
is
a
novel
direction
for
tumor
therapy.
Unfortunately,
the
current
use
of
statins
hepatocellular
carcinoma
(HCC)
controversial.
Herein,
farnesyl-diphosphate
farnesyltransferase
1
(FDFT1)
identified
as
target
treating
HCC
and
potential
alternative
to
statins.
Twenty-three
key
genes
in
biosynthesis
are
screened,
FDFT1
via
public
databases
(The
Cancer
Genome
Atlas,
International
Consortium
Gene
Expression
Omnibus).
Clinical
samples
reveal
that
highly
expressed
tissues,
this
phenotype
strongly
associated
with
poor
prognosis.
Functionally,
knockdown
inhibits
proliferation
metastasis
cells
suppresses
hepatocarcinogenesis
vitro
vivo,
whereas
overexpression
promotes
cell
metastasis.
Mechanistically,
downregulation
decreases
bile
acid
levels
then
increases
hepatocyte
nuclear
factor
4
alpha
(HNF4A)
transcriptional
activity.
Experiments
indicate
HNF4A
combines
promoter
aldolase
B
(ALDOB)
ALDOB
transcription
AKT
serine/threonine
kinase
(AKT1)
AKT1
phosphorylation.
Moreover,
combined
inhibitor
(AZD5363)
treatment
shows
remarkable
therapeutic
potential.
inhibition
reduces
delay
progression
through
HNF4A/ALDOB/AKT1
axis.
Thus,
targeting
may
be
strategy
HCC.
Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
199, P. 107037 - 107037
Published: Dec. 7, 2023
Sirtuins,
also
called
silent
information
regulator
2,
are
enzymes
that
rely
on
nicotinamide
adenine
dinucleotide
(NAD+)
to
function
as
histone
deacetylases.
Further
investigation
is
warranted
explore
the
advantageous
impacts
of
Sirtuin
1
(SIRT1),
a
constituent
sirtuin
group,
lipid
metabolism,
in
addition
its
well-researched
involvement
extending
lifespan.
The
regulation
gene
expression
has
been
extensively
linked
SIRT1.
Sterol
regulatory
element-binding
protein
(SREBP)
substrate
SIRT1
attracted
significant
interest
due
role
multiple
cellular
processes
including
cell
cycle
regulation,
DNA
damage
repair,
and
metabolic
functions.
Hence,
objective
this
analysis
was
investigate
elucidate
correlation
between
SREBPs,
well
assess
contribution
SIRT1/SREBPs
mitigating
metabolism
dysfunction.
research
whether
SREBPs
could
be
utilized
viable
targets
for
therapeutic
intervention
managing
complications
associated
with
diabetes.
Cell Metabolism,
Journal Year:
2023,
Volume and Issue:
35(11), P. 1852 - 1871
Published: Nov. 1, 2023
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
an
unabated
risk
factor
for
end-stage
diseases
with
no
available
therapies.
Dysregulated
immune
responses
are
critical
culprits
of
MASLD
pathogenesis.
Independent
contributions
from
either
the
innate
or
adaptive
arms
system
their
unidirectional
interplay
commonly
studied
in
MASLD.
However,
bidirectional
communication
between
and
systems
its
impact
on
remain
insufficiently
understood.
Given
that
both
cells
indispensable
development
progression
inflammation
MASLD,
elucidating
pathogenic
stemming
these
two
holds
potential
novel
therapeutics
Here,
we
review
cell
types
pathways
influence
pathogenesis
highlight
pharmacologic
approaches
to
combat
based
current
knowledge
this
crosstalk.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(8), P. 7463 - 7463
Published: April 18, 2023
Hepatocellular
carcinoma
is
the
most
common
primary
liver
cancer,
ranking
third
among
leading
causes
of
cancer-related
mortality
worldwide
and
whose
incidence
varies
according
to
geographical
area
ethnicity.
Metabolic
rewiring
was
recently
introduced
as
an
emerging
hallmark
able
affect
tumor
progression
by
modulating
cancer
cell
behavior
immune
responses.
This
review
focuses
on
recent
studies
examining
HCC’s
metabolic
traits,
with
particular
reference
alterations
glucose,
fatty
acid
amino
metabolism,
three
major
changes
that
have
gained
attention
in
field
HCC.
After
delivering
a
panoramic
picture
peculiar
landscape
HCC,
this
will
also
discuss
how
reprogramming
cells
can
affect,
directly
or
indirectly,
microenvironment
function
different
populations,
eventually
favoring
escape
from
immunosurveillance.
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
202, P. 107126 - 107126
Published: March 1, 2024
PD-1
blockade
therapy
has
made
great
breakthroughs
in
treatment
of
multiple
solid
tumors.
However,
patients
with
microsatellite-stable
(MSS)
colorectal
cancer
(CRC)
respond
poorly
to
anti-PD-1
immunotherapy.
Although
CRC
microstatellite
instability
(MSI)
or
microsatellite
instability-high
(MSI-H)
can
benefit
from
therapy,
there
are
still
some
problems
such
as
tumor
recurrence.
Tumor-associated
macrophages
(TAMs),
most
abundant
immune
components
microenvironment
(TME),
largely
limit
the
therapeutic
efficacy
against
CRC.
The
CSF1/CSF1R
pathway
plays
a
key
role
regulating
macrophage
polarization,
and
blocking
CSF1R
signaling
transduction
may
be
potential
strategy
effectively
reprogram
remodel
TME.
Here,
we
found
that
increasing
expression
predicted
poor
prognosis
cohort.
Furthermore,
discovered
novel
potent
inhibitor,
PXB17,
which
significantly
reprogramed
M2
M1
phenotype.
Mechanically,
PXB17
blocked
activation
PI3K/AKT/mTORC1
signaling,
resulting
inhibition
cholesterol
biosynthesis.
Results
3D
co-culture
system
suggested
PXB17-repolarized
could
induce
infiltration
CD8+
T
lymphocytes
tumors
improve
immunosuppressive
microenvironment.
In
vivo,
halted
growth,
stronger
effect
than
PLX3397.
particular,
potently
enhanced
activity
mAb
CT-26
model
prevented
recurrence
MC-38
by
promoting
formation
long-term
memory
immunity.
Our
study
opens
new
avenue
for
innate
adaptive
anti-tumor
immunomodulatory
suggests
is
promising
immunotherapy
molecule
enhancing
reducing
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 8, 2024
Growing
evidence
indicates
that
cellular
metabolism
is
a
critical
determinant
of
immune
cell
viability
and
function
in
antitumor
immunity
lipid
important
for
activation
adaptation
to
the
tumor
microenvironment
(TME).
Lipid
peroxidation
process
which
oxidants
attack
lipid-containing
carbon-carbon
double
bonds
an
part
metabolism.
In
past
decades,
studies
have
shown
participates
signal
transduction
control
proliferation,
differentiation,
death,
essential
execution
human
health.
More
importantly,
recent
affects
modulate
ability.
this
review,
we
briefly
overview
effect
on
adaptive
innate
TME
discuss
effectiveness
sensitivity
ability
cells
by
regulating
peroxidation.